Literature DB >> 8674898

Advanced glycation end products and their recognition by macrophage and macrophage-derived cells.

S Horiuchi1, T Higashi, K Ikeda, T Saishoji, Y Jinnouchi, H Sano, R Shibayama, T Sakamoto, N Araki.   

Abstract

Modification of proteins by long-term incubation with glucose leads to the formation of advanced glycation end products (AGEs). AGE proteins are taken up by macrophages via the AGE receptor, which is similar to the macrophage scavenger receptor (MSR). In the present study, we compared the ligand specificity of the AGE receptor with that of MSR by three different experiments. The endocytic uptake of 125I-acetyl-LDL by RAW cells was effectively inhibited by unlabeled AGE-bovine serum albumin (BSA), whereas the inhibitory effect of acetyl-LDL on 125I-AGE-BSA was partial. Polyanions showing an effective inhibition for endocytic uptake of AGE-BSA were not always inhibitory for endocytic degradation of acetyl-LDL. These data, together with those obtained by three-dimensional fluorescence-activated cell sorter analysis, indicate that AGE proteins are recognized by more than two receptors, of which MSR is at least one. Finally, we examined whether MSR could mediate the endocytic uptake of AGE proteins by Chinese hamster ovary cells overexpressing bovine type II MSR (CHO-SRII cells). 125I-AGE-BSA underwent endocytic degradation by CHO-SRII cells, and this was effectively inhibited by unlabeled acetyl-LDL. These results clearly show that MSR mediates the endocytic uptake of AGE proteins, suggesting a new role of MSR in biological recognition of AGE in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674898     DOI: 10.2337/diab.45.3.s73

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

Review 1.  Advanced glycation: an important pathological event in diabetic and age related ocular disease.

Authors:  A W Stitt
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

2.  Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides.

Authors:  Annunziata Lapolla; Domenico Fedele; Rachele Reitano; Nadia Concetta Aricò; Roberta Seraglia; Pietro Traldi; Ester Marotta; Roberto Tonani
Journal:  J Am Soc Mass Spectrom       Date:  2004-04       Impact factor: 3.109

3.  Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A).

Authors:  K Nakajou; S Horiuchi; M Sakai; N Haraguchi; M Tanaka; M Takeya; M Otagiri
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

4.  Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease.

Authors:  M Butscheid; P Hauptvogel; P Fritz; U Klotz; D M Alscher
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

5.  Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease.

Authors:  Henry H Ruiz; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

Review 6.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

7.  Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor.

Authors:  Weijing Cai; John C He; Li Zhu; Changyong Lu; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

8.  Advanced glycation of type I collagen and fibronectin modifies periodontal cell behavior.

Authors:  Jesse Murillo; Yao Wang; Xiaoping Xu; Robert J Klebe; Zhihua Chen; Gustavo Zardeneta; Sanjay Pal; Margarita Mikhailova; Bjorn Steffensen
Journal:  J Periodontol       Date:  2008-11       Impact factor: 6.993

9.  Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.

Authors:  Catherine B Renard; Farah Kramer; Fredrik Johansson; Najib Lamharzi; Lisa R Tannock; Matthias G von Herrath; Alan Chait; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

10.  Aging and atherosclerosis in human and nonhuman primates.

Authors:  W T Cefalu; J D Wagner
Journal:  Age (Omaha)       Date:  1997-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.